Jetema signs ₩10.1bn exclusive medical filler supply contract
Jetema filed a ₩10.1bn exclusive supply contract for medical device (filler) products with a domestic distributor. The contract period runs from Oct 14, 2026 to Oct 14, 2031, and the amount is 13.1% of revenue as reported.
Key facts
| Contract name | Exclusive supply of medical devices (fillers) |
|---|---|
| Counterparty | domestic distributor |
| Contract amount | ₩10.1bn |
| % of revenue (as reported) | 13.1% |
| Period start | Oct 14, 2026 |
| Period end | Oct 14, 2031 |
Comparison
| Amount as % of FY2025 revenue (calculated) | 13.1% |
|---|---|
| Revenue 2025 | ₩76.9bn |
| Revenue 2024 | ₩68.5bn |
| Revenue 2023 | ₩58.7bn |
Context
In the 12 months before this filing, Jetema filed 2 supply contracts totaling ₩34.9bn, which is 45.3% of prior-year revenue.
Key metrics
Supply contracts
| Supply contracts, last 12 months | ₩75.1bn |
|---|---|
| Supply contracts vs prior-year revenue | 97.6% |
| Contracts without a KRW amount | 0 contracts without a KRW amount excluded |
Related filings
Source: DART (Financial Supervisory Service) · Original filing on DART ↗